Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Pfizer partner BioNTech starts cancer vaccine phase 2 trial

<< Previous

Bullboard Posts

Next >>

Comment by Oilminerdeluxeon Jun 23, 2021 1:10pm

174 Views

Post# 33434938

RE:RE:RE:RE:RE:RE:Pfizer partner BioNTech starts cancer vaccine phase 2 trial

That potential immune reponse is feeding the imaginations of my feeble mind. I think the company wants several patients at once when they report stuff, not one or two (my interpretation), but one would think that more than that would be enough to warrant an update. At least if it's a good one. I could use me a success. It's never easy, that's for sure.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec